Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct;32(4):637-43.
doi: 10.1093/schbul/sbl003. Epub 2006 Jun 16.

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

Mary F Brunette  1 , Robert E Drake, Haiyi Xie, Gregory J McHugo, Alan I Green
Affiliations

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

Mary F Brunette et al. Schizophr Bull. 2006 Oct.

Abstract

Background: Previous correlational research with schizophrenic patients has suggested that the second-generation antipsychotic medication clozapine helps to induce remissions of substance use disorder in patients with co-occurring psychosis and substance abuse. This research, however, could be biased by selection factors. Studying patients who are currently in substance abuse remission could control for level of motivation to stop using substances and other methodological confounds.

Methods: To test whether clozapine was associated with prevention of substance abuse relapses, we examined patients with schizophrenia or schizoaffective disorder who were in their first 6-month remission of substance use disorder during a prospective 10-year follow-up study. All patients received yearly multimodal assessments of substance use. Antipsychotic medications were prescribed by community doctors as part of usual clinical care.

Results: Patients using clozapine at the first 6-month period of substance abuse remission (n = 25) were much less likely to relapse over the next year compared with those on other antipsychotic medications (n = 70): 8.0% vs 40.0%, chi(2) = 8.73 (df = 1), P = .003. Although medication assignment was not randomized, several potential confounders were similar between the groups.

Conclusion: Clozapine should be considered for the treatment of patients with schizophrenia and co-occurring substance use disorder to prevent relapses to substance abuse.

PubMed Disclaimer

Comment in

References

    1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;32(4):637–643. - PubMed
    1. Dixon L. Dual diagnosis of substance abuse in schizophrenia: Prevalence and impact on outcomes. Schizophr Res. 1999;35(suppl):S93–S100. - PubMed
    1. Linszen D, Dingemans P, Lenior M. Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psychiatry. 1994;51:273–279. - PubMed
    1. Gerding LB, Labbate LA, Measom MO, Santos AB, Arana GW. Alcohol dependance and hospitalization in schizophrenia. Schizophr Res. 1999;38:71–75. - PubMed
    1. Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzin LB. Substance use: A powerful predictor of relapse in schizophrenia. Schizophr Res. 1996;20:145–151. - PubMed

Publication types